Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: PRUCALOPRIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for prucalopride, enabling a generic version for chronic idiopathic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)